scholarly journals Morphological and Physiological Characterization of Pyramidal Neuron Subtypes in Rat Medial Prefrontal Cortex

2013 ◽  
Vol 25 (3) ◽  
pp. 788-805 ◽  
Author(s):  
Karlijn I. van Aerde ◽  
Dirk Feldmeyer
1989 ◽  
Vol 173 (2-3) ◽  
pp. 193-196 ◽  
Author(s):  
Charles R. Ashby ◽  
Emmeline Edwards ◽  
Kelly Harkins ◽  
Rex Y. Wang

2018 ◽  
Vol 34 (5) ◽  
pp. 759-768
Author(s):  
Yan-Lin He ◽  
Kai Wang ◽  
Qian-Ru Zhao ◽  
Yan-Ai Mei

2018 ◽  
Vol 29 (10) ◽  
pp. 4334-4346 ◽  
Author(s):  
Jian-Ming Yang ◽  
Chen-Jie Shen ◽  
Xiao-Juan Chen ◽  
Ying Kong ◽  
Yi-Si Liu ◽  
...  

Abstract erbb4 is a known susceptibility gene for schizophrenia. Chandelier cells (ChCs, also known as axo-axonic cells) are a distinct GABAergic interneuron subtype that exclusively target the axonal initial segment, which is the site of pyramidal neuron action potential initiation. ChCs are a source of ErbB4 expression and alterations in ChC-pyramidal neuron connectivity occur in the medial prefrontal cortex (mPFC) of schizophrenic patients and animal models of schizophrenia. However, the contribution of ErbB4 in mPFC ChCs to the pathogenesis of schizophrenia remains unknown. By conditional deletion or knockdown of ErbB4 from mPFC ChCs, we demonstrated that ErbB4 deficits led to impaired ChC-pyramidal neuron connections and cognitive dysfunctions. Furthermore, the cognitive dysfunctions were normalized by L-838417, an agonist of GABAAα2 receptors enriched in the axonal initial segment. Given that cognitive dysfunctions are a core symptom of schizophrenia, our results may provide a new perspective for understanding the etiology of schizophrenia and suggest that GABAAα2 receptors may be potential pharmacological targets for its treatment.


Sign in / Sign up

Export Citation Format

Share Document